C07D 279/10
1,4-thiazines
Official title: 1,4-Thiazines; Hydrogenated 1,4-thiazines
C07D279/10 (1,4-thiazines) appears on 995 US grants and 834 published applications in this corpus.
Search patents in C07D- Granted patents
- 995
- Published applications
- 834
- Assignees
- 575
- Inventors
- 2,775
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 6 | 0 |
| 1977 | 7 | 0 |
| 1978 | 23 | 0 |
| 1979 | 5 | 0 |
| 1980 | 19 | 0 |
| 1981 | 15 | 0 |
| 1982 | 9 | 0 |
| 1983 | 13 | 0 |
| 1984 | 12 | 0 |
| 1985 | 10 | 0 |
| 1986 | 16 | 0 |
| 1987 | 17 | 0 |
| 1988 | 11 | 0 |
| 1989 | 18 | 0 |
| 1990 | 17 | 0 |
| 1991 | 21 | 0 |
| 1992 | 17 | 0 |
| 1993 | 29 | 0 |
| 1994 | 18 | 0 |
| 1995 | 5 | 0 |
| 1996 | 17 | 0 |
| 1997 | 16 | 0 |
| 1998 | 28 | 0 |
| 1999 | 18 | 0 |
| 2000 | 10 | 0 |
| 2001 | 25 | 6 |
| 2002 | 31 | 33 |
| 2003 | 18 | 30 |
| 2004 | 21 | 31 |
| 2005 | 13 | 26 |
| 2006 | 16 | 30 |
| 2007 | 19 | 26 |
| 2008 | 13 | 34 |
| 2009 | 15 | 28 |
| 2010 | 25 | 44 |
| 2011 | 20 | 35 |
| 2012 | 26 | 31 |
| 2013 | 24 | 32 |
| 2014 | 29 | 38 |
| 2015 | 27 | 45 |
| 2016 | 38 | 45 |
| 2017 | 37 | 31 |
| 2018 | 29 | 45 |
| 2019 | 35 | 34 |
| 2020 | 26 | 53 |
| 2021 | 37 | 26 |
| 2022 | 26 | 24 |
| 2023 | 17 | 35 |
| 2024 | 14 | 30 |
| 2025 | 21 | 26 |
| 2026 | 16 | 16 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Electrochromic devices and compositions including anodic component anions15 Sep 2026US 12,735,392 B2Vitro Flat Glass LLC
- Small molecule BAX inhibitors and uses thereof18 Aug 2026US 12,708,621 B2Albert Einstein College of Medicine
- Method of inhibiting tau phosphorylation7 Jul 2026US 12,674,134 B2Filana Therapeutics, Inc.
- Organic electroluminescent element and electronic device using same30 Jun 2026US 12,668,739 B2Idemitsu Kosan Co., Ltd.
- Method of inhibiting tau phosphorylation23 Jun 2026US 12,662,658 B2Filana Therapeutics, Inc.
- Electrochromic Devices and Compositions Including Anodic Component Anions1 Oct 2026US 2026/0297043 A1Vitro Flat Glass LLC
- Hdac1/2 selective inhibitor and use thereof1 Oct 2026US 2026/0297110 A1Wigen Biomedicine Technology (Shanghai) Co., Ltd.
- Mitochondrial therapeutic agents10 Sep 2026US 2026/0265209 A1Arizona Board of Regents on behalf of Arizona State University
- Compounds for the treatment of neuromuscular disorders16 Jul 2026US 2026/0199369 A1Nmd Pharma A/S
- Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives16 Jul 2026US 2026/0200844 A1OrsoBio, Inc.
Most cited
By later US patents
- Process for preparing diaminophenothiazinium compounds687US 8,765,942 B2Provence Technologies · 2014
- Electrode mediators for regeneration of NADH and NADPH190US 5,498,542 ABayer Aktiengesellschaft · 1996
- 1,3-propane diol esters and ethers and methods for their use in drug delivery162US 6,555,700 B1Scotia Holdings PLC · 2003
- Modulators of ATP-binding cassette transporters157US 7,495,103 B2Vertex Pharmaceuticals Incorporated · 2009
- Fatty acid esters as bioactive compounds147US 6,245,811 B1Scotia Holdings PLC · 2001